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Background: Physicians often classify patients’ osteoarthritis (OA) severity subjectively. As treatment
decisions are inﬂuenced by severity classiﬁcations, it is important to understand the factors that inﬂu-
ence physicians’ OA severity ratings. This research sought to empirically identify physician and patient
characteristics that lead to a patient being perceived as having more severe OA.
Methods: Data were analyzed from the OA IX Disease Speciﬁc Program, a large cross-sectional survey of
OA physicians and patients in Germany, the UK, and USA between September 2011 and January 2012.
Eligible, consenting physicians completed a Patient Record Form (PRF) for 10 consecutive OA patients.
The PRF asked physicians to report the patient’s demographics [age, gender, body mass index (BMI),
ethnicity], their assessment of the patients’ symptom severity, treatment, probability for surgery, to rate
their overall OA severity (mild, moderate or severe) and the factors that had inﬂuenced the rating.
Chi-squared tests and analysis of variance were used to identify patient characteristics that signiﬁcantly
impacted physicians’ OA severity ratings. Controlling for the signiﬁcant patient characteristics, we then
examined the impact of physician specialty on physician’s OA severity ratings. Finally, we investigated
the differences in physician-reported factors that inﬂuenced the physicians’ rating of patients’ severity
between physician specialties.
Results: Three hundred and sixty-three physicians [220 primary care physicians (PCPs), 48 rheumatol-
ogists, 95 orthopedic surgeons] recruited 3561 patients. Patients with greater age and BMI, worse
symptoms and greater health care use were given higher OA severity ratings. Controlling for these
factors, orthopedic surgeons rated their OA patients as more severe than PCPs and rheumatologists
[adjusted odds ratio (OR) 1.8, 95% conﬁdence interval (CI) 1.4e2.4]. Specialists (rheumatologists and
orthopedic surgeons) were more likely than PCPs to use joint spaced narrowing based on X-ray and
severity of joint deterioration radiographic severity to assess patients’ OA severity (joint space nar-
rowing: 79% and 78% vs 55%, P < 0.0001).
Conclusions: Patient age, BMI, presence and severity of symptoms and health care use signiﬁcantly
impacted physicians’ OA severity ratings, but radiographic changes appeared to be given greater weight
among orthopedic surgeons and rheumatologists than PCPs when assessing patient severity. Whether
these differences translate into different treatment recommendations for similar patients is unknown,
and warrants study.
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Osteoarthritis (OA) is the most common arthritis and is esti-
mated to affect 9.6% of men and 18.0% of women globally1,2. Pa-
tients experience pain and stiffness and the condition is the sixth
leading cause of years living with a disability2. There is no cure for
OA and treatment aims to alleviate symptoms and slow the pro-
gression of the disease3. Management options include lifestyle
changes (weight loss, physical activity), pharmacological and non-td. All rights reserved.
Table I
Univariate relationship between physician-reported patient characteristics and physician-perceived severity
Variables Overall (n ¼ 3561) Current severity P-value
Mild (n ¼ 886) Moderate (n ¼ 1852) Severe (n ¼ 823)
Physician-reported patient demographics
Age, mean (SD) 64.5 (12.2) 61.8 (11.9) 64.8 (12.1) 66.7 (12.5) <0.0001
Male, N (%) 1546 (43.4) 377 (42.6) 819 (44.3) 350 (42.5) 0.5818
BMI, mean (SD) 29.6 (6.6) 28.5 (5.8) 29.8 (6.7) 30.3 (7.1) <0.0001
Caregiver involved, N (%) 394 (11.3) 49 (5.7) 200 (11.0) 145 (18.0) <0.0001
# CV conditions, mean (SD) 1 (1.2) 0.7 (0.9) 1 (1.2) 1.2 (1.3) <0.0001
# AI conditions, mean (SD) 0.1 (0.3) 0.1 (0.3) 0.1 (0.3) 0.1 (0.3) 0.0587
# GI conditions, mean (SD) 0.3 (0.7) 0.3 (0.6) 0.4 (0.7) 0.4 (0.7) <0.0001
# Other conditions, mean (SD) 0.8 (1.2) 0.6 (0.9) 0.9 (1.3) 1 (1.3) <0.0001
Level of adherence (0e10)y, mean (SD) 8.2 (1.9) 8.4 (1.9) 8.1 (1.9) 8 (1.9) <0.0001
Physician-reported OA related measures
Pain rating (0e10)*, mean (SD) 5.2 (2.1) 3.1 (1.6) 5.2 (1.5) 7.2 (1.4) <0.0001
Functionality rating (0e10)*, mean (SD) 4.8 (2.2) 2.9 (2.1) 4.8 (1.8) 6.7 (1.7) <0.0001
# Joints affected, mean (SD) 3.3 (2.9) 2.5 (1.8) 3.5 (3.0) 3.8 (3.2) <0.0001
Level of analgesia (0e10)*, mean (SD) 4.6 (2.4) 2.7 (1.8) 4.7 (2.1) 6.5 (2.1) <0.0001
Physician-reported symptoms ever suffered by patient, N (%)
Joint tenderness 2552 (73.5) 570 (65.7) 1363 (75.5) 619 (77.5) <0.0001
Tiredness/lethargy 814 (23.4) 134 (15.4) 417 (23.1) 263 (32.9) <0.0001
Stiffness in the morning 2066 (59.5) 489 (56.3) 1075 (59.5) 502 (62.8) 0.0263
Stiffness in joints overall 1505 (43.3) 282 (32.5) 821 (45.5) 402 (50.3) <0.0001
Pain on movement 2997 (86.3) 718 (82.7) 1546 (85.6) 733 (91.7) <0.0001
Pain at rest 1833 (52.8) 326 (37.6) 939 (52.0) 568 (71.1) <0.0001
Persistent lower back pain 1174 (33.8) 185 (21.3) 649 (35.9) 340 (42.6) <0.0001
Nocturnal wakening 786 (22.6) 103 (11.9) 380 (21.0) 303 (37.9) <0.0001
Loss of movement 1326 (38.2) 181 (20.9) 689 (38.2) 456 (57.1) <0.0001
Loss of grip 497 (14.3) 115 (13.2) 245 (13.6) 137 (17.1) 0.0325
Swollen joints 1140 (32.8) 207 (23.8) 605 (33.5) 328 (41.1) <0.0001
Cracking joints 988 (28.4) 173 (19.9) 520 (28.8) 295 (36.9) <0.0001
Cramp 258 (7.4) 38 (4.4) 126 (7.0) 94 (11.8) <0.0001
Physician-reported physician involvement
# Consultations in the last 12 months, mean (SD) 2.9 (2.7) 2.3 (1.8) 2.8 (2.3) 3.9 (3.7) <0.0001
Other physician involved, N (%) 721 (20.5) 130 (14.8) 378 (20.6) 213 (26.3) <0.0001
Physician-reported patient surgery status, N (%)
Surgery undertaken 641 (18.3) 157 (18.2) 268 (14.7) 216 (26.6) <0.0001
Surgical candidate 761 (21.8) 46 (5.3) 365 (20.0) 350 (43.1)
Neither 1705 (48.7) 556 (64.4) 951 (52.2) 198 (24.4)
Don’t know 391 (11.2) 105 (12.2) 237 (13.0) 49 (6.0)
SD: standard deviation; CV: cardiovascular; AI: autoimmune; GI: gastrointestinal.
Bold text indicates characteristics that are signiﬁcant.
A P-value pertains to whether there is a difference in means (for a continuous outcome) or a difference in proportions (for a categorical) between at least two of the three
groups (mild, moderate or severe).
* A higher score indicates a worse state.
y A higher score indicates a better level.
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serve or replace the joint4,5.
Treatment decisions are inﬂuenced by a number of factors
including the physicians’ and patients’ perceptions of the severity
of disease4,6. However, the physician’s assessment of the severity of
disease asmild, moderate or severe is likelymulti-factorial andmay
be inﬂuenced by patient socio-demographic characteristics, patient
reported symptoms, functional limitations, and structural joint
severity based on radiologic ﬁndings. The relative importance of
these aspects of disease severity in determining physicians’ per-
ceptions of their patients’ OA severity is not well understood, nor
whether there are differences by physician specialty. This latter
issue is of particular relevance given that patients with OA may
receive care from many different physicians, including a primary
care physician (PCP), a rheumatologist, and/or an orthopedic sur-
geon. Different approaches to disease severity assessment might
delay progression to specialist care and joint replacement or,
conversely, might result in inappropriate surgical intervention
when alternative therapy might be more appropriate7.
Against this background, the current analysis was undertaken in
order to identify physician and patient characteristics that lead to a
patient being perceived as having more or less severe OA.Methods
All data came from the OA IX Disease Speciﬁc Program (DSP), a
large, cross-sectional multinational survey that captures robust,
real-world data8. DSPs are run independently and with no set hy-
potheses. The data captured is a representation of physicians’
behavior in real-world clinical practice and provides in depth
market understanding of a speciﬁc disease area. The survey was
conducted between September 2011 and January 2012, including
orthopedic surgeons, rheumatologists and PCPs from two European
countries, the United Kingdom and Germany, and the United States
of America.
Physician participants were identiﬁed from public lists of health
care professionals according to predeﬁned selection criteria: prac-
ticing physicians in one of three specialties (orthopedic surgery,
rheumatology, primary practice) and seeing more than 10
conﬁrmed OA patients in a typical month. Candidate respondents
were screened by telephone and those who met the predeﬁned
eligibility criteria were invited to participate.
Each eligible and consenting physician completed a Patient
Record Form (PRF) for 10 consecutively seen OA patients,
regardless of the reason for the visit and irrespective of the
Table II
Impact of physician-reported patient characteristics on physician-perceived severity
(initial regression model)
Patient attribute Pseudo
R2 ¼ 0.3519
OR 95% CI
Age 1.016 1.009 1.024
BMI 1.014 1.001 1.027
Pain rating (0e10)* 2.264 2.042 2.510
Function rating (0e10)* 1.231 1.146 1.324
OA symptoms ever suffered (ref ¼ never)
Stiffness in the morning (vs no
stiffness in the morning)
0.809 0.667 0.980
Pain on movement (vs no pain on movement) 1.478 1.103 1.981
Pain at rest (vs no pain at rest) 1.509 1.254 1.816
Nocturnal wakening (vs no nocturnal wakening) 1.336 1.060 1.683
Loss of movement (vs no loss of movement) 1.392 1.134 1.710
Loss of grip (vs no loss of grip) 0.751 0.580 0.971
Cracking joints (vs not cracking joints) 1.232 1.014 1.496
Number of consultations in last 12 months 1.085 1.047 1.123
Characteristics included in the initial model that were removed during the stepwise
process: caregiver involvement, number of conditions suffered, level of adherence,
number of joints affected, analgesia level, other physician involvement and ever
suffering from joint tenderness, tiredness/lethargy, stiffness in joints overall,
persistent lower back pain, swollen joints and cramp.
For a continuous predictor the OR represents the odds of receiving a more severe
perceived severity rating for a one unit increase in the continuous predictor. For a
categorical predictor, the OR represents the odds of receiving a more severe grade
compared to the referent group noted in brackets.
* A higher score indicates a worse state.
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report: patient demographics [age, gender, body mass index
(BMI), ethnicity], whether a caregiver was involved in the pa-
tient’s daily needs, speciﬁc comorbid conditions, level of adher-
ence to treatment [11-point visual analog scale (VAS) with
anchors at 0 ¼ not adherent and 10 ¼ full adherence], overall
severity of pain and function (VAS from 0 ¼ no pain/fully func-
tional to 10 ¼ worse imaginable pain/fully impaired function),
other OA symptoms (ever suffered/suffered in past 4 weeks),
current analgesia requirement (0 ¼ no analgesia required and
10 ¼ strongest possible analgesia required, e.g., opioid analgesic),Table III
Impact of physician specialty on physician-perceived severity
Patient attribute Pseudo
R2 ¼ 0.3581
OR 95% CI
Physician specialty
Orthopedic surgeon 1.823 1.405 2.365
Age 1.019 1.011 1.026
BMI 1.017 1.004 1.030
Pain rating (0e10)* 2.265 2.045 2.508
Functionality rating (0e10)* 1.226 1.141 1.317
OA symptoms ever suffered (ref ¼ never)
Stiffness in the morning (vs no
stiffness in the morning)
0.816 0.673 0.989
Pain on movement (vs no pain on movement) 1.475 1.103 1.973
Pain at rest (vs no pain at rest) 1.542 1.282 1.854
Nocturnal wakening (vs no nocturnal wakening) 1.326 1.058 1.663
Loss of movement (vs no loss of movement) 1.361 1.109 1.671
Loss of grip (vs no loss of grip)y 0.786 0.610 1.012
Cracking joints (vs not cracking joints) 1.255 1.034 1.523
Number of consultations in last 12 months 1.078 1.041 1.117
For a continuous predictor the OR represents the odds of receiving a more severe
perceived severity rating for a one unit increase in the continuous predictor. For a
categorical predictor, the OR represents the odds of receiving a more severe grade
compared to the referent group noted in brackets.
* A higher score indicates a worse state.
y No longer signiﬁcant.probability for surgery, to rate the current overall OA severity
(mild, moderate or severe) and, from a list of factors, to indicate
those that had inﬂuenced this rating. Doctor data were de-
identiﬁed and disaggregated prior to receipt by Adelphi Real
World. This research adhered to version 6.3 of the EphMRA code
of conduct governing market research9.
Statistical analysis
The relationship between physician-reported patient char-
acteristics and physician-reported OA severity rating (three-
level outcome) was assessed using chi-squared tests for cate-
gorical characteristics (variables) and analysis of variance for
continuous characteristics. Those associated with physician-
rated OA severity (P < 0.05) were then included in an ordered
logistic regression model10 using a backward stepwise approach
and controlling for physician clustering to determine the in-
dependent effect they had on physician-reported OA severity.
Physician specialty was then added to the model to investigate
the impact, if any, on physician-perceived OA severity rating.
Chi-squared tests were performed to investigate if there were
any differences in the factors physicians’ considered to rate
patients’ OA severity between physician specialties. In second-
ary analyses, we then examined for country differences by
stratifying the ﬁnal regression model and the chi-squared tests
by country and comparing these to the combined population
results.
McFadden’s pseudo R-squared values were used to assess the ﬁt
of each model, whilst the proportional odds assumptionwas tested
for in each model using the Brant test11. All statistical analysis was
conducted using STATA 12.112.
Results
There were 363 physicians (220 PCPs, 95 orthopedic surgeons
and 48 rheumatologists) who recruited, and recorded, an OA
severity for, 3561 patients, 24.9% of whom were assessed as mild,
52.0% moderate, and 23.1% severe.
Association between physician-reported patient characteristics and
physician-perceived severity (Table I)
All physician-reported patient characteristics had a signiﬁcant
association with physicians’ overall OA severity ratings, with the
exception of patient gender and number of autoimmune conditions
(Table I).
Impact of physician-reported patient characteristics on physician-
perceived severity (Tables II and III)
In multivariate analysis, the odds of a patient receiving a higher
OA severity rating from their physician was greater if the patient
was older, had a greater BMI, had receivedmore OA consultations in
the last 12 months, had more intense pain, worse function, and had
ever suffered from pain at rest, on movement, or at night, had loss
of movement or cracking joints, while having ever suffered from
morning stiffness or loss of grip reduced the odds (Table II). Con-
trolling for these patient factors, the odds of receiving a higher OA
severity rating was 1.8 times as likely if the patient consulted with
an orthopedic surgeon compared to a PCP or rheumatologist
(Table III). McFadden’s pseudo R-squared value for the adjusted
model was 0.36 compared to 0.35 for the initial model, suggesting
the model ﬁt had improved slightly with the inclusion of physician
specialty.
Table IV
How the reasons given for assigning a patient with a severity rating differ for different physician specialties
Reasons given for assigning severity rating, N (%) Overall
(N ¼ 3618)
PCP
(N ¼ 2199)
Orthopedic surgeon
(N ¼ 945)
Rheumatologist
(N ¼ 474)
P-value
Joint space narrowing based on X-ray 2324 (64.2) 1218 (55.4) 734 (77.7) 372 (78.5) <0.0001
Frequency of pain symptom(s) 2610 (72.1) 1633 (74.3) 641 (67.8) 336 (70.9) 0.0009
Severity of pain symptom(s) 2932 (81.0) 1810 (82.3) 732 (77.5) 390 (82.3) 0.0048
Ability to work/employment 856 (23.7) 499 (22.7) 224 (23.7) 133 (28.1) 0.0446
KLG scale 72 (2.0) 15 (0.7) 34 (3.6) 23 (4.9) <0.0001
Impairment in the ability to function
(e.g., walk, activities of daily living)
2115 (58.5) 1281 (58.3) 557 (58.9) 277 (58.4) 0.9376
Number of joints affected by OA 857 (23.7) 515 (23.4) 181 (19.2) 161 (34.0) <0.0001
Severity of joint deterioration 1280 (35.4) 676 (30.7) 424 (44.9) 180 (38.0) <0.0001
Increase in dose and/or frequency of
drugs patient needs to control their OA
501 (13.8) 326 (14.8) 116 (12.3) 59 (12.4) 0.1055
Osteoporosis 262 (7.2) 125 (5.7) 90 (9.5) 47 (9.9) <0.0001
Other 39 (1.1) 21 (1.0) 17 (1.8) 1 (0.2) 0.0161
Bold text indicates characteristics that are signiﬁcant.
A P-value pertains to whether there is a difference in proportions between at least two of the three groups (PCP, orthopedic surgeon, rheumatologist).
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differ for different physician specialties (Table IV)
Rheumatologists and orthopedic surgeons were more likely to
indicate the use of joint spaced narrowing based on X-ray and the
severity of joint deterioration in their assessment of patients’ OA
severity compared to PCPs (X-ray joint space narrowing: rheuma-
tologists 79%, orthopedic surgeons 78%, PCPs 55%, P < 0.0001; joint
deterioration: rheumatologists 38%, orthopedic surgeons 45%, PCPs
31%, P < 0.0001), but did not differ with respect to the importance
of other factors (Table IV).
Secondary analyses e by country (Table V)
Of the 3623 collected patients, 1752 were collected from the
USA, 871 from the UK and 1000 from Germany. The breakdown of
physicians and consulting patients by country is shown in Table V.
When our ﬁnal models were rerun separately for each of the three
countries, results were not substantially different (data not shown)
and were consistent with the overall population. Similarly, factors
related to assignment of patient OA severity ratings were similar
across the three countries, with a few exceptions. In Germany, pain
frequency was not signiﬁcant across physician types (P ¼ 0.1660),
while in the UK the ability toworkwas reported as being signiﬁcant
(P ¼ 0.0001), in both Germany and the UK functional impairment
was reported as signiﬁcant across physician types (P ¼ 0.0001 and
P ¼ 0.0016 respectively). The objective measures [joint space
deterioration and KellgreneLawrence grade (KLG)] remained sig-
niﬁcant across physician type in all the countries.
Discussion
To our knowledge, this is the ﬁrst study to examine the impact of
patient and physician characteristics on physician-reported OA
severity ratings for their patients. In a large clinical sample of OA
patients from Europe and the USA, we found that physicians’Table V
Patient and physician numbers split by country
Physician type Country
Germany UK USA
PCP 600 (60) 600 (60) 1002 (100)
Orthopedic surgeon 310 (31) 186 (19) 450 (45)
Rheumatologist 90 (9) 85 (9) 300 (30)
Table content: Patient (n) [Physician (n)].evaluated OA severity based on the patient’s age, reported fre-
quency and intensity of joint pain and disability and radiographic
ﬁndings. Controlling for these patient factors, orthopedic surgeons
rated patient’s severity as worse compared to rheumatologists and
PCPs. The results presented here suggest that this effect could in
part be due to a greater inﬂuence of radiographic ﬁndings on OA
severity rating.
Our observations are consistent with previous studies that
suggest that orthopedic surgeons place relatively greater impor-
tance on X-ray ﬁndings than on patient symptoms in determining
patients’ need for joint replacement. In focus groups conducted in
OA patients to determine their perceptions of ‘appropriateness’ for
joint replacement surgery, Frankel et al. found that participants felt
the intensity of joint pain, and its impact on quality of life, should be
the most important factor determining patients’ appropriateness
for joint replacement, but that this element of OA severity was
inadequately assessed by surgeons13. In an international study that
examined levels of pain, disability and radiographic severity of
patients with hip and knee OAwhowere seen in consultation by an
orthopedic surgeon regarding joint replacement, symptom severity
had low predictive validity for identifying those who did versus did
not receive a recommendation for surgical intervention14.
Possible explanations for why surgeons may place greater
importance on radiographic changes than other physician spe-
cialties include the need to ensure they are operating on ‘diseased’
joints. Although plain radiographs are relatively insensitive in early
OA to detect structural changes consistent with this diagnosis, the
concordance between symptoms and structure improves as the
disease progresses15. Structural changes at the level of the joint
would also be important in decision making by surgeons regarding
surgical approach16, and relatively more important in patiente
physician decisionmaking regarding the need for surgery than non-
operative OA therapies17. Further studies are needed to elucidate
explanations for this specialty difference and if conﬁrmed, whether
or not it impacts provision of appropriate OA care.
Strengths of this study include its large size and the breadth of
patient characteristics that were considered. However, there were
also some limitations. First, our physician participants represent a
convenience sample; thus, we cannot conclude that these ﬁndings
may be generalizable to all physicians practicing in these spe-
cialties. Second, we evaluated OA patients who were presenting for
care. While this may have introduced a bias in that the patient
cohort may represent those whose disease state has changed or
advanced, the authors believe that this was unlikely to affect the
overall results of the analysis undertaken here as this potential
selection bias applied equally across physician specialties.
J. Bailey et al. / Osteoarthritis and Cartilage 22 (2014) 647e651 651In conclusion, while patient age and presence and severity of OA
symptoms were similarly weighted in physicians’ ratings of their
patients OA severity, orthopedic surgeons appear to give greater
weight than rheumatologists and PCPs to radiographic ﬁndings.
Whether these differences in the approach used to assess OA
severity impact referrals to specialist care and/or provision of joint
replacement is unknown, and warrants further evaluation.
Contributions
James Bailey made substantial contributions to the conception
and design of the study and interpretation of the data, was involved
in the drafting of the article, critical revisions and approved the
ﬁnal version for submission. JB also takes responsibility for the
integrity of the work as a whole, from inception to ﬁnished article.
Gillian A. Hawker MD provided clinical direction and input to
the objective of the analysis, made substantial contributions to
interpretation of data, critical revisions and approved the ﬁnal
version for submission.
Robert Wood made substantial contributions to the statistical
analysis and interpretation of the data, critical revisions and
approved the ﬁnal version for submission.
Joseph C. Cappelleri made substantial contributions to the sta-
tistical analysis and interpretation of the data, critical revisions and
approved the ﬁnal version for submission.
Victoria Higgins made substantial contributions to the concep-
tion and design of the study and interpretation of the data, critical
revisions and approved the ﬁnal version for submission.
Nina Joyce was involved in the drafting of the article and critical
revisions.
Ming-Ann Hsu made substantial contributions to the design of
the study, interpretation of the data, critical revisions and approved
the ﬁnal version for submission.
Conﬂict of interests
JB, RW and VH are employees of Adelphi Real World. JC, NJ and
MAH are employees of Pﬁzer Inc. Gillian A. Hawker, MD, is
employed by theWomen’s College Hospital & University of Toronto,
Canada.
Role of the funding source
Pﬁzer (_100004319) Inc provided funding support for the current
analysis.
References
1. Centers for Disease Control (CDC). Arthritis Types: Osteoar-
thritis. http://www.cdc.gov/arthritis/basics/osteoarthritis.htm
#2 (accessed 21.08.12).
2. Woolf AD, Pﬂeger B. Burden of major musculoskeletal condi-
tions. Bull World Health Organ 2003;81(646):656.
3. Schaap LA, Peeters GM, Dennison EM, Zambon S, Nikolaus T,
Sanchez-Martinez M, et al. European Project on OSteoArthritis
(EPOSA): methodological challenges in harmonization ofexisting data from ﬁve European population-based cohorts on
aging. BMC Musculoskelet Disord 2011;12:272.
4. Michael JWP, Schluter KU, Eysel P. The epidemiology, etiology,
diagnosis and treatment of osteoarthritis of the knee. Dtsch
Arztebl Int 2010;107:152e62.
5. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J,
Gunther KP, et al. EULAR evidence based recommendations for
the management of hip osteoarthritis: report of a task force of
the EULAR Standing Committee for International Clinical
Studies Including Therapeutics (ESCISIT). Ann Rheum Dis
2005;64:669e81.
6. Sadosky AB, Bushmakin AG, Cappelleri JC, Lionberger DR.
Relationship between patient-reported disease severity in
osteoarthritis and self-reported pain, function and work pro-
ductivity. Arthritis Res Ther 2010;12:R162e70.
7. Zeni Jr JA, Axe MJ, Snyder-Mackler L. Clinical predictors of
elective total joint replacement in persons with end-stage
knee osteoarthritis. BMC Musculoskelet Disord 2010;11:86.
8. Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-
world physician and patient behaviour across countries:
disease-speciﬁc programmes e a means to understand. Curr
Med Res Opin 2008;24:3063e72.
9. EphMRA. European Pharmaceutical Market Research Associa-
tion Guidelines. http://www.ephmra.org (Last accessed 20.
09.12).
10. Kleinbaum DG, Klein M. Logistic Regression: A Self-learning
Text. 3rd edn. New York, NY: Springer; 2010.
11. Long JS, Freese J. Regression Models for Categorical and
Limited Dependent Variables Using Stata. 2nd edn. College
Station, Texas: Stata Press; 2006.
12. StataCorp. Stata Statistical Software: Release 12. College Sta-
tion, TX: StataCorp LP; 2011.
13. Frankel L, Sanmartin C, Conner-Spady B, Marshall DA,
Freeman-Collins L, Wall A, et al. Osteoarthritis patients’ per-
ceptions of “appropriateness” for total joint replacement sur-
gery. Osteoarthritis Cartilage 2012;20:967e73.
14. Gossec L, Paternotte S, Maillefert JF, Combescure C,
Conaghan PG, Davis AM, et al. The role of pain and functional
impairment in the decision to recommend total joint
replacement in hip and knee osteoarthritis: an international
cross-sectional study of 1909 patients. Osteoarthritis Cartilage
2011;19:147e54.
15. Lachance L, Sowers M, Jamadar D, Jannausch M, Hochberg M,
et al. The experience of pain and emergent osteoarthritis of the
knee. Osteoarthritis Cartilage 2001;9:527e32.
16. Quintana JM, Escobar A, Arostegui I, Bilbao A, Azkarate J,
Goenaga JI, et al. Health related quality of life and appropri-
ateness of knee or hip joint replacement. Arch Intern Med
2006;166:220e6.
17. Frankel L, Sanmartin C, Conner-Spady Z, Marshall DA,
Freeman-Collins L, Wall A, et al. Osteoarthritis patients’ per-
ceptions of “appropriateness” for total joint replacement sur-
gery. Osteoarthritis Cartilage 2012;20:967e73.
